Cargando…
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells
The anti-hyperglycemic drug glibenclamide (Glb) might represent an interesting therapeutic option in human neurodegenerative diseases because of its anti-inflammatory activity and its ability to downregulate activation of the NLRP3 inflammasome. Bi-functionalized liposomes that can cross the blood–b...
Autores principales: | Mancuso, Roberta, Citterio, Lorenzo Agostino, Agostini, Simone, Marventano, Ivana, La Rosa, Francesca, Re, Francesca, Seneci, Pierfausto, Saresella, Marina, Clerici, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675475/ https://www.ncbi.nlm.nih.gov/pubmed/38004455 http://dx.doi.org/10.3390/ph16111590 |
Ejemplares similares
-
Serum and Exosomal miR-7-1-5p and miR-223-3p as Possible Biomarkers for Parkinson’s Disease
por: Citterio, Lorenzo Agostino, et al.
Publicado: (2023) -
miR-23a-3p and miR-181a-5p modulate SNAP-25 expression
por: Agostini, Simone, et al.
Publicado: (2023) -
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
por: Mancuso, Roberta, et al.
Publicado: (2019) -
MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability
por: Singh, Sandeep, et al.
Publicado: (2020) -
miR-3113-5p, miR-223-3p, miR-133a-3p, and miR-499a-5p are sensitive biomarkers to diagnose sudden cardiac death
por: Yan, Fengping, et al.
Publicado: (2021)